Utility of Intermittent Cryo-Compression Versus Traditional Icing Following Arthroscopic Rotator Cuff Repair

NCT ID: NCT05095909

Last Updated: 2023-03-15

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 100 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2023-03-31
• Study Completion Date: 2025-06-30

Brief Summary

Effective post - operative pain control following orthopedic surgical procedures without excessive reliance upon opioid pain medication has garnered increased attention in recent years. This study will evaluate the utilization of a non-invasive, novel cryo - compression, post-operative modality to improve pain control versus standard ice wraps in the immediate post-operative phase of arthroscopic rotator cuff surgery via a randomized controlled study design. Furthermore, if this study demonstrates improved pain control, improved quality of life and decreased opioid usage with the intermittent cold compression unit, recommendations may be considered for system-wide utilization.

Detailed Description

The purpose of this study is to test the proposed increase efficacy of combining both cold and compression modalities through cryo-compression therapy in post-operative pain management in arthroscopic rotator cuff repair surgery versus a control group of standard ice wraps. As opioid use within the field of orthopedics continues to grow as an area of investigation, surgeons must look elsewhere for pain management tactics.

Objectives of this study include:

1. Evaluate effectiveness of intermittent cryo-compression therapy versus standard ice wraps for post - operative pain control through patient reported visual analog pain scores and patient - reported opioid usage in patients undergoing arthroscopic rotator cuff repair.

2. Evaluate effectiveness of intermittent cryo-compression therapy versus standard ice wraps for reduction of post - operative tissue swelling in patients undergoing arthroscopic rotator cuff repair.

3. Determine cost comparison of intermittent compression cryotherapy versus interscalene catheter via historical controls as well as versus standard ice wraps.

4. Evaluate effect of intermittent cryo-compression therapy versus standard ice wraps on patient - reported quality of life via PROMIS.

Patients that are candidates for arthroscopic rotator cuff repair and complete informed consent process will be enrolled in study if no exclusion criteria are present. The study has determined an enrollment goal of 100 subjects (50 intermittent cryo-compression therapy, 50 standard cryo -therapy).

Following informed consent, patients enrolled in the study will be randomized in a 1:1 ratio using permuted blocks of sizes 2 and 4 to have post-operative cryotherapy using ice packs or with the intermittent cold compression therapy unit. Randomization assignments will be contained in sequentially numbered, opaque, sealed envelopes, which will be prepared by an individual not involved in patient consent or patient treatment. After the patient is consented, the next envelope in the sequence will be opened and the patient will be assigned to a group following the treatment listed in the envelope.

Prior to surgery, the subject will complete pre-operative data collection. The subject will be given a tracking diary in order to record immediate post-operative data through the first post-operative visit. Subjects will undergo arthroscopic rotator cuff repair by a single surgeon as a standard of care procedure.

Subjects randomized to the study group will have the compression sleeve for the NICE Recovery SystemTM applied to the operative shoulder immediately post - operatively and those randomized to the control group a standard gel ice pack with wrap. Each will use the assigned version of cold therapy with a goal of 6 hours daily and will record overages using one half hour as a minimum unit.

After enrollment and surgery, subjects will follow a post-operative follow-up visit schedule including 2-days, first post-operative visit, 60 days, 3 months, 6 months, and 12 months.

Conditions

Rotator Cuff Injuries; Cryotherapy Effect

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Cryo-compression

Fitted with compression sleeve for the NICE Recovery SystemTM applied to the operative shoulder immediately post - operatively Minimum 6 hours treatment per day post-operatively. Utilize cyro-compression unit with a "Medium" compression level (inflate to 35 mmHg for 2 minutes and then deflate to 5 mmHg for 30 seconds) and "Level 3" cooling (50F (10C)) for the first 24 hours. After that time, the compression and cooling levels will be up to the patients' discretion.

Group Type: EXPERIMENTAL

Cryo-compression

Intervention Type: DEVICE

Programmable intermittent compression with integrated cryo-therapy.

Cryo-therapy

Fitted with a standard gel ice pack with wrap immediately post-operatively. Minimum 6 hours treatment per day using gel ice packs.

Group Type: ACTIVE_COMPARATOR

Cryo-therapy

Intervention Type: OTHER

Subjects are fitted with gel ice packs and wraps.

Interventions

Cryo-compression

Programmable intermittent compression with integrated cryo-therapy.

Intervention Type: DEVICE

Cryo-therapy

Subjects are fitted with gel ice packs and wraps.

Intervention Type: OTHER

Other Intervention Names

NICE Cold Therapy; Gel ice pack

Eligibility Criteria

Inclusion Criteria

1. Patients who are candidates for arthroscopic rotator cuff repair

1. Acute, traumatic tear of the rotator cuff in an active patient

2. Chronic, symptomatic tear of the rotator cuff in an active patient having failed non - operative treatment

2. Patient agreeable to participation in the study and able to complete informed consent process and all study requirements.

3. ≥18 years of age

Exclusion Criteria

1. Pregnancy (per pre-operative physical)

2. Presence of significant glenohumeral joint osteoarthritis

3. Age over 70

4. History of clinically diagnosed lymphedema

5. Morbid obesity (BMI > 45)

6. History of drug or alcohol addiction, prior opioid dependence, or current use of opioid medication (preoperative)

7. Investigators concern regarding subject's ability or willingness to follow protocol.

8. History of significant vascular impairment in the affected region (e.g., from prior frostbite, diabetes, arteriosclerosis or ischemia).

9. History of acute paroxysmal cold hemoglobinuria or cryoglobulinemia.

10. History of Raynaud's disease or cold hypersensitivity (cold urticarial).

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 70 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Allina Health System

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

L Pearce McCarty III, MD

Role: PRINCIPAL_INVESTIGATOR

Allina Health

Locations

Allina Health Orthopedics

Plymouth, Minnesota, United States

Site Status: RECRUITING

Countries

United States

Central Contacts

Ned Tervola, MA, LAT, ATC

Role: CONTACT

ned.tervola@allina.com

952-946-9777

Facility Contacts

Ned K Tervola, MA, LAT, ATC

Role: primary

ned.tervola@allina.com

952-946-9777

Other Identifiers

ICC2-2019

Identifier Type: -

Identifier Source: org_study_id